Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers

A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder

ClinicalTrials.gov ID: NCT00685113

Public ClinicalTrials.gov record NCT00685113. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 3:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of Two Doses of DR-3001 Versus Placebo in Women With Overactive Bladder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter study to evaluate the efficacy and safety of 2 different doses of DR-3001. For eligible subjects the duration of the study will be approximately 20 weeks; this will consist of a 4-week screening period, a 12-week treatment period and a 4-week follow-up period. Subjects will have physical and laboratory exams, including blood draws at each scheduled visit. Subjects will be required to insert a vaginal ring (replacing it every 4 weeks) and to keep a daily record of their toilet voids (including time,type and volume) for 3 days at several specified time points.

Study identification

NCT ID
NCT00685113
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Duramed Research
Industry
Enrollment
1,104 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2008
Primary completion
Feb 28, 2010
Completion
Feb 28, 2010
Last update posted
Jul 19, 2016

2008 – 2010

United States locations

U.S. sites
81
U.S. states
31
U.S. cities
71
Facility City State ZIP Site status
Duramed Investigational Site Huntsville Alabama 35801
Duramed Investigational Site Mobile Alabama 36608
Duramed Investigational Site Montgomery Alabama 36116
Duramed Investigational Site Phoenix Arizona 85015
Duramed Investigational Site Tucson Arizona 85712
Duramed Investigational Site Tucson Arizona 85741
Duramed Investigational Site Little Rock Arkansas 72205
Duramed Investigational Site Encinitas California 92024
Duramed Investigational Site Los Angeles California 90036
Duramed Investigational Site San Diego California 92103
Duramed Investigational Site San Diego California 92108
Duramed Investigational Site San Diego California 92123
Duramed Investigational Site Colorado Springs Colorado 80909
Duramed Investigational Site Denver Colorado 80220
Duramed Investigational Site Danbury Connecticut 06810
Duramed Investigational Site Milford Connecticut 06460
Duramed Investigational Site New London Connecticut 06320
Duramed Investigational Site Aventura Florida 33180
Duramed Investigational Site Gainesville Florida 32607
Duramed Investigational Site Jacksonville Florida 32207
Duramed Investigational Site Miami Florida 33143
Duramed Investigational Site New Port Richey Florida 34655
Duramed Investigational Site Tampa Florida 33607
Duramed Investigational Site West Palm Beach Florida 33407
Duramed Investigational Site West Palm Beach Florida 33409
Duramed Investigational Site Atlanta Georgia 30308
Duramed Investigational Site Augusta Georgia 30901
Duramed Investigation Site Decatur Georgia 30034
Duramed Investigational Site Savannah Georgia 31406
Duramed Investigational Site Boise Idaho 83704
Duramed Investigational Site Boise Idaho 83712
Duramed Investigational Site Coeur d'Alene Idaho 83814
Duramed Investigational Site Meridian Idaho 83642
Duramed Investigational Site Fort Wayne Indiana 46825
Duramed Investigational Site Jeffersonville Indiana 47130
Duramed Investigational Site South Bend Indiana 46601
Duramed Investigational Site Newton Kansas 67114
Duramed Investigational Site Wichita Kansas 67207
Duramed Investigational Site Louisville Kentucky 40291
Duramed Investigational Site Lafayette Louisiana 70503
Duramed Investigational Site Marrero Louisiana 70072
Duramed Investigational Site Shreveport Louisiana 71106
Duramed Investigational Site Watertown Massachusetts 02472
Duramed Investigational Site Las Vegas Nevada 89109
Duramed Investigational Site Las Vegas Nevada 89128
Duramed Investigational Site North Las Vegas Nevada 89030
Duramed Investigational Site Lebanon New Hampshire 03756
Duramed Investigational Site Lawrenceville New Jersey 08648
Duramed Investigational Site Moorestown New Jersey 08057
Duramed Investigational Site New Brunswick New Jersey 08901
Duramed Investigational Site Albuquerque New Mexico 87102
Duramed Investigational Site Port Jefferson New York 11777
Duramed Investigational Site New Bern North Carolina 28562
Duramed Investigational Site Winston-Salem North Carolina 27103
Duramed Investigational Site Cleveland Ohio 44122
Duramed Investigational Site Mayfield Heights Ohio 44124
Duramed Investigational Site Bethany Oklahoma 73008
Duramed Investigational Site Oklahoma City Oklahoma 73112
Duramed Investigational Site Eugene Oregon 97401
Duramed Investigational Site Medford Oregon 97504
Duramed Investigational Site Philadelphia Pennsylvania 19104
Duramed Investigational Site Philadelphia Pennsylvania 19114
Duramed Investigational Site Pittsburgh Pennsylvania 15206
Duramed Investigational Site Pottstown Pennsylvania 19464
Duramed Investigational Site Charlestown South Carolina 29425
Duramed Investigational Site Columbia South Carolina 29201
Duramed Investigational Site Greensville South Carolina 29605
Duramed Investigational Site Hilton Head Island South Carolina 29926
Duramed Investigational Site Jackson Tennessee 38305
Duramed Investigational Site Dallas Texas 75234
Duramed Investigational Site Dallas Texas 75390
Duramed Investigational Site Dallas Texas 78229
Duramed Investigational Site Houston Texas 77024
Duramed Investigational Site San Antonio Texas 78209
Duramed Investigational Site San Antonio Texas 78229
Duramed Investigational Site Waco Texas 76712
Duramed Investigational Site Salt Lake City Utah 84107
Duramed Investigational Site Williston Vermont 05495
Duramed Investigational Site Norfolk Virginia 23507
Duramed Investigational Site Seattle Washington 98105
Duramed Investigational Site Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00685113, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 19, 2016 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00685113 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →